Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders??? Equity

v3.22.1
Consolidated Statement of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 5 $ 214,397 $ (208,758) $ 5,644
Balance (in Shares) at Dec. 31, 2019 5,490,038      
Stock-based compensation 1,254 1,254
Stock-based compensation (in Shares) 6,262      
Sale of common stock and warrants, net of offering costs $ 9 76,580 76,589
Sale of common stock and warrants, net of offering costs (in Shares) 8,575,051      
Issuance of common stock from exercise of pre-funded warrants $ 4 6 10
Issuance of common stock from exercise of pre-funded warrants (in Shares) 3,458,929      
Issuance of common stock from exercise of warrants 37 37
Issuance of common stock from exercise of warrants (in Shares) 2,613      
Deemed dividend for warrant down-round protection provision   1 (1)  
Net loss (22,215) (22,215)
Balance at Dec. 31, 2020 $ 18 292,275 (230,974) 61,319
Balance (in Shares) at Dec. 31, 2020 17,532,893      
Stock-based compensation   1,694   1,694
Stock-based compensation (in Shares) 21,306      
Sale of common stock, net of offering costs $ 4 35,296   35,300
Sale of common stock, net of offering costs (in Shares) 4,588,875      
Issuance of common stock from exercise of stock options   6 6
Issuance of common stock from exercise of stock options (in Shares) 900      
Net loss (24,774) (24,774)
Balance at Dec. 31, 2021 $ 22 $ 329,271 $ (255,748) $ 73,545
Balance (in Shares) at Dec. 31, 2021 22,143,974